Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical lidocaine versus placebo before onabotulinumtoxinA bladder injections
2021-000559-38Phase 3Completed
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in urge incontinence (2 arms), sponsored by Herlev & Gentofte Hospital. Primary endpoint: Discomfort or pain during onabotulinumtoxinA injections. Started Nov 2021; status: completed.
02
Drugs
lidocaine
03
Conditions
urge incontinence
Beyond the preview
Go deeper on 2021-000559-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000559-38.